Efficacy, Safety and Tolerability of Enteric-Coated Cholestyramine Capsules for Adult Short Bowel Syndrome
Phase 2
Terminated
- Conditions
- Short Bowel Syndrome
- Interventions
- Drug: Placebo
- First Posted Date
- 2019-08-06
- Last Posted Date
- 2022-07-19
- Lead Sponsor
- Pharmascience Inc.
- Target Recruit Count
- 13
- Registration Number
- NCT04046328
- Locations
- 🇵🇱
Solumed Centrum Medyczne, Poznań, Poland
🇵🇱Wojewódzki Specjalistyczny Szpital im. M. Pirogowa w Łodzi, Łódź, Poland
🇵🇱Szpital Wielospecjalistyczny im. Stanleya Dudricka, Skawina, Poland
Early Effect of Cingal® Compared to Monovisc® in Patients With Osteoarthritis of the Knee
Not Applicable
Completed
- Conditions
- Osteoarthritis, Knee
- Interventions
- Device: Monovisc® (Sodium hyaluronate)Device: Cingal® (Hyaluronic Acid plus Triamcinolone Hexacetonide)
- First Posted Date
- 2017-02-23
- Last Posted Date
- 2020-04-21
- Lead Sponsor
- Pharmascience Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT03062787
- Locations
- 🇨🇦
Site 04, Barrie, Ontario, Canada
🇨🇦Site 02, Kanata, Ontario, Canada
🇨🇦Site 03, Hamilton, Ontario, Canada
© Copyright 2025. All Rights Reserved by MedPath